Objective: The aim of this study was to identify the independent effect of very preterm gestation on breast milk content of biologically active proteins (secretory immunoglobulin A (sIgA), lysozyme, lactoferrin, osteoprotegerin (OPG), leptin, adiponectin and b-endorphin (b-EP)) during the first month of lactation.
Introduction
Extensive research documents the diverse and compelling advantages of breastfeeding due to not only the value of different nutrients but also availability of the biologically active proteins. [1] [2] [3] [4] Among the breast milk bioactive proteins are secretory immunoglobulin A (sIgA), lysozyme, lactoferrin, osteoprotegerin (OPG), leptin, adiponectin and b-endorphin (b-EP) that have anti-infective, immune 5, 6 and/or neuroendocrine properties. [7] [8] [9] It has been suggested that preterm delivery may affect the concentration of some of these bioactive breast milk proteins. 3,10 -12 As compared to term breast milk (TBM), preterm breast milk (PBM) is reported to have higher sIgA, 12 higher 13 or similar 14 lactoferrin, comparable lysozyme, 13,14 OPG 7 and b-EP, 3 and lower leptin 10 levels. A few studies have looked at differences in preterm gestational age at delivery, stage of lactation, 3 ,10 parity 11, 15 and mode of delivery. 3 Very preterm gestation is associated with impaired adaptation to the new environment, dysfunction of different organ systems and excessive infection-related neonatal morbidity. [16] [17] [18] The delivery of biologically active proteins through the breast milk can be beneficial for very preterm infants. However, it is still not clear whether breast milk from mothers delivering at very preterm gestation is able to provide their infants with comparable amounts of sIgA, lysozyme, lactoferrin, OPG, leptin, adiponectin and b-EP.
In this study, we determined and compared concentrations of sIgA, lysozyme, lactoferrin, OPG, leptin, adiponectin and b-EP during the first month of lactation in breast milk from mothers who delivered at very preterm and term gestations. The independent effect of very preterm gestation on the content of these proteins was studied in regression models by including the mode of delivery and parity.
The results of this study will further knowledge regarding breast milk as a source of bioactive proteins for very preterm born infants and may help optimize the feeding of very preterm neonates.
Methods
This study was approved by the institutional review board at Robert Wood Johnson Medical School. Mothers of any race/ethnicity, age and parity who delivered preterm infants at 24 to 31 weeks or term gestation (38 to 41 weeks) and breastfed their infants were included in this study. Signed informed consent was required for participation in this study. We excluded mothers who were smokers or drug users or diagnosed with human immunodeficiency virus.
Serial samples of hind milk were obtained during the first 29 days postpartum from mothers giving birth prematurely and at term. Sample collection was standardized to reduce bias and potential diurnal variability. The mothers were asked to collect 3 ml of the milk that flowed toward the end of a feeding or a breast pumping session. The samples of transitional (days 6 to 8 and 13 to 15) and mature hind milk (days 20 to 22 and 27 to 29) were collected in plastic tubes by the mothers in conjunction with the first feeding or by hand/pump expression in the morning (between 0800 and 0900 hours). The collected milk samples were cooled, vortexed and divided into 250 ml aliquots (0.5 ml microcentrifuge tubes). Skimmed milk (aqueous phase) was prepared by centrifugation (1500 g, 20 min, 4 1C), after which the fat layer was removed. All collected samples were frozen at À70 1C in plastic microcontainers until further assay. After the completion of the study enrollment and specimen collection, the milk samples were thawed at room temperature before being processed further.
The clinical (gestational age, birth weight, parity, mode of delivery and intrapartum complications and medications) and demographic data (maternal age and race/ethnicity) of the enrolled mothers were collected.
Analytical methods
Each sample was assayed in duplicate and measurements were carried out as per the manufacturer's directions. If necessary, samples were diluted using Dulbecco's modified Eagle's medium.
After appropriate dilution, enzyme-linked immunosorbent assay (ELISA) or enzyme immunoassay kits were used to quantify the levels of sIgA, lysozyme, lactoferrin, OPG, leptin, adiponectin and b-EP: (i) sIgA ELISA kit (ALPCO Diagnostics, Windham, NH, USA) with sensitivity 13.4 ng ml À1 , intra-and interassay coefficient of variation 5 to 9% and 7.4 to 8%, respectively.
(ii) Lysozyme enzyme immunoassay kit (Biomedical Technologies, Stoughton, MA, USA) with sensitivity 0.78 ng ml
À1
, intra-and interassay coefficients of variation 5.3 and 7%, respectively. (iii) Lactoferrin enzyme immunoassay kit (Oxis International, Foster City, CA, USA) with sensitivity 1.0 ng ml À1 , intra-and interassay coefficients of variation 5.0 and 9.6%, respectively. (iv) OPG ELISA kit (ALPCO Diagnostics) with sensitivity 0.14 pmol l À1 , intra-and interassay coefficient of variation <10%. (v) Leptin ELISA kit (Diagnostic Systems Laboratories, Webster, TX, USA) with sensitivity 0.1 ng ml À1 , intra-and interassay coefficient of variation 3.7 to 6.6% and 2.6 to 3.7%, respectively. (vi) Adiponectin ELISA kit (Linco Research, St. Charles, MO, USA) with sensitivity 0.5 ng ml
, intra-and interassay coefficient of variation 1.0 to 7.4% and 2.4 to 8.4%, respectively. (vii) b-EP ELISA kit (MD Biosciences, St. Paul, MN, USA) with sensitivity 1 pg ml À1 , intra-and interassay coefficient of variation <5% and <14%, respectively.
Statistical analysis
We analyzed the data using descriptive statistics, correlation and regression analysis. The continuous data was tested for normality using the Shapiro-Wilk W-test. Analysis of variance was used to compare the variation in the measured human milk bioactive proteins between the TBM and PBM. We used w 2 analysis to compare the categorical data. Friedman analysis of variance was used to compare the tested parameters in association with the different stages of lactation (6 to 8, 13 to 15, 20 to 22 and 27 to 29 days). We used regression analysis to identify the association between the tested bioactive proteins and gestational age after adjustment for parity and mode of delivery. Data are presented as mean ± standard deviation (s.d.), percentage (%), regression coefficient (b) and standard error of b (s.e.). Statistical significance was accepted with P<0.05.
Results
A total of 80 samples of breast milk were provided by 20 mothers who consented to the study: 15 who delivered at very preterm gestations (28±2.2 weeks) and 5 at term (38.8±0.8 weeks). Nulliparity was recorded in all the term and 40% of the very preterm deliveries (P<0.02). No difference was observed in the race/ethnicity and maternal age. The preterm deliveries were associated with preeclampsia (33.3%), premature rupture of membranes (33.3%), treatment with magnesium sulfate (66.6%) and antibiotics (60%). Cesarean section was seen in 66.7% of preterm and 40% of term deliveries (P>0.05).
Comparison of sIgA, lysozyme, lactoferrin, OPG, leptin, adiponectin and b-EP levels between PBM and TBM A comparison of the tested bioactive proteins in the TBM and PBM during the first month of lactation is presented in Figure 1 . As compared to TBM, the concentrations of lactoferrin and OPG were significantly lower in PBM at 6 to 8 and 13 to 15 days, respectively, and sIgA was higher at 6 to 8 days of lactation. We found significantly lower levels of leptin in PBM than in TBM but no difference in lysozyme, b-EP and adiponectin during the first month of lactation.
Changes in concentration of sIgA, lysozyme, lactoferrin, OPG, leptin, adiponectin and b-EP during the first month of lactation (from transitional to mature milk) in PBM and TBM samples In both PBM and TBM, the concentrations of lysozyme, lactoferrin, leptin, adiponectin and b-EP decreased and sIgA did not change significantly during the first month of lactation (P<0.05 to Regression analysis to identify the impact of gestational age on the tested parameters after adjustment for mode of delivery and parity (b ± s.e.) The associations between very preterm gestation and sIgA, lactoferrin, lysozyme, OPG, b-EP, leptin and adiponectin levels in breast milk were tested in regression models that included gestational age, parity and mode of delivery. Very preterm delivery was found to be associated with higher sIgA, lysozyme and adiponectin in the transitional milk but lower lactoferrin, OPG and leptin (P<0.05 to 0.0001). A similar pattern was observed in the concentrations of lysozyme, leptin and adiponectin in mature milk. Increased b-EP levels in breast milk were associated with the vaginal mode of delivery in transitional as well as mature milk (P<0.0001). The concentration of adiponectin in transitional milk was higher in association with nulliparity (P<0.05).
Discussion
This is the first study that simultaneously evaluated sIgA, lysozyme, lactoferrin, OPG, leptin, adiponectin and b-EP levels in transitional as well as mature milk from mothers who delivered at term versus Biologically active breast milk proteins R Mehta and A Petrova those delivering at very preterm gestations. We found that change from the transitional to the mature stage of lactation did not affect the sIgA but decreased the lysozyme, lactoferrin, OPG, leptin, adiponectin and b-EP levels in TBM and PBM. The duration of lactation has been previously reported to be associated with decreased sIgA, lysozyme, lactoferrin, b-EP 3, 11, 19 and adiponectin 4 in TBM and/or PBM, and either an increase 20 or no change in leptin content of mature PBM 2,10 and TBM. 10 Our findings are in accord with others 21, 22 showing PBM to be a valuable exogenous source of adaptive immunity and antibacterial activity because of the higher concentration of sIgA and lysozyme. Moreover, PBM has a higher concentration of adiponectin, a factor that reduces the production of proinflammatory cytokines. 23 Conversely, transitional PBM is deficient in (1) lactoferrin, a major component of innate immunity; 19 (2) OPG, the natural regulator of bone metabolism 7 and (3) leptin, which is involved in regulation of the neuroendocrine system. 8 Mature PBM showed a similar pattern of differences in lysozyme, adiponectin and leptin levels. Our results differ from others as regards lysozyme, lactoferrin and OPG. 7, 13, 14, 19 We found that vaginal delivery was associated with an increase in breast milk b-EP, 3 which may be relevant for postnatal adaptation because of its functional activity as an opioid neurotransmitter and immunomodulator. 3 Our findings of an association between higher concentrations of adiponectin in PBM and milk from nulliparous mothers are new. A previous study 4 had reported decreased adiponectin in TBM from Hispanic mothers of Mexican descent.
There are several limitations in this study. We did not analyze maternal nutrition and postpartum adiposity, although these factors may influence some of the tested breast milk components. 4, 24 However, the data in the medical literature is inconsistent and some studies have shown no effect of nutrition and/or adiposity on the milk content of lactoferrin, lysozyme, sIgA and leptin. 25, 26 We used a smaller sample of mothers who delivered at term but the data was collected consistently (four times) during the first month of lactation and found to be normally distributed. There is some discrepancy between our results and other reports perhaps due to differences in the time of breast milk collection and studies not taking into account the degree of prematurity, parity and mode of delivery, variables that may significantly affect the bioactive protein levels. 3, 11, 15, 25 In conclusion, transitional milk after term as well as preterm delivery is superior to mature milk in terms of the content of the bioactive proteins. Breast milk from mothers who deliver at less than 32 weeks of gestation is a good source of factors that have antibacterial and anti-inflammatory activities but is constantly deficient in leptin, which is involved in the regulation of the neuroendocrine system.
